Vasopressin excess and hyponatremia

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Phuong-Chi T PhamPhuong-Thu T Pham

Abstract

Hyponatremia is a common electrolyte disorder that frequently is overlooked and undertreated. Although the pathophysiological process of hyponatremia is complex, arginine vasopressin (AVP) is a common etiologic factor. Excess AVP release by osmotic or nonosmotic stimuli or both can lead to sodium and water imbalance. Conventional treatment options for hyponatremia, including water restriction and administration of sodium chloride with or without loop diuretics, do not directly address the underlying water retention induced by excess AVP in many cases. Clinical trials showed that AVP-receptor antagonists, including lixivaptan, tolvaptan, and conivaptan, produce aquaresis, the electrolyte-sparing excretion of free water, to correct serum sodium concentration. We review results from recent clinical trials involving AVP-receptor antagonists in the treatment of hyponatremia associated with AVP excess.

References

Jul 1, 1976·Kidney International·G L RobertsonS Athar
Aug 1, 1975·The Journal of Clinical Investigation·R J AndersonR W Schrier
Oct 1, 1990·The Journal of Clinical Investigation·A G RobinsonT G Sherman
Aug 1, 1989·Baillière's Clinical Endocrinology and Metabolism·P H Baylis
Oct 1, 1986·Journal of the American College of Cardiology·S R GoldsmithJ N Cohn
Nov 1, 1986·Journal of General Internal Medicine·W M TierneyC J McDonald
Feb 1, 1985·Clinics in Endocrinology and Metabolism·A G Robinson
Feb 1, 1985·Annals of Internal Medicine·R J AndersonR W Schrier
Dec 1, 1973·The Journal of Clinical Investigation·F L DunnG L Robertson
May 1, 1967·The American Journal of Medicine·F C Bartter, W B Schwartz
Sep 20, 1984·The New England Journal of Medicine·P A PhillipsL Wollner
Jun 27, 1980·JAMA : the Journal of the American Medical Association·P D MillerR W Schrier
Jan 1, 1980·Annual Review of Medicine·R ZerbeG Robertson
Feb 1, 1994·Journal of General Internal Medicine·C TerzianZ H Piotrowski
Nov 1, 1995·Journal of the American Society of Nephrology : JASN·E MulkerrinB A Clark
May 1, 1997·The Medical Clinics of North America·L F Fried, P M Palevsky
Jan 1, 1997·The American Journal of Medicine·C L Fraser, A I Arieff
Sep 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P GinésR W Schrier
Apr 22, 1999·Postgraduate Medical Journal·G Gill, G Leese
May 29, 2000·The New England Journal of Medicine·H J Adrogué, N E Madias
Jun 1, 2000·The American Journal of Emergency Medicine·C T LeeJ B Chen
Dec 5, 2000·Renal Failure·T E Andreoli
Jan 6, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G BorroniF Salerno
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·M ThibonnierM Shoham
Oct 20, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·R L Thunhorst, A K Johnson
May 16, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Edward M StrickerAlan F Sved
Dec 4, 2002·Journal of Clinical Pathology·B O SaeedJ U Weaver
Dec 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Florence WongPaul J Thuluvath
Jan 10, 2003·Clinical Endocrinology·San-E Ishikawa, Robert W Schrier
Apr 16, 2003·The Medical Clinics of North America·Lisa C Costello-BoerrigterJohn C Burnett
Apr 23, 2003·La Revue de médecine interne·S-L BennaniO Kerkeb
Jun 10, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ole Skøtt
Jun 26, 2003·The International Journal of Biochemistry & Cell Biology·Peter H Baylis
Jul 10, 2003·American Heart Journal·Craig R LeeKirkwood F Adams
Oct 15, 2003·Archives of Surgery·Andrew E Luckey, Cyrus J Parsa
Dec 23, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Joseph G Verbalis
Dec 23, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Andrés Cárdenas, Vicente Arroyo
Apr 29, 2004·JAMA : the Journal of the American Medical Association·Mihai GheorghiadeUNKNOWN Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators
Aug 17, 2004·The American Journal of Medicine·Alexander GoldbergDoron Aronson
Feb 19, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Andres E RufFederico G Villamil

❮ Previous
Next ❯

Citations

Dec 29, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Johannes JacobiKarl F Hilgers
Dec 31, 2008·World Journal of Gastroenterology : WJG·Bahaa Eldeen Senousy, Peter V Draganov
Apr 12, 2013·Nephro-urology Monthly·Nematollah Jonaidi JafariAmin Saburi
Feb 19, 2011·Chest·Taka-Aki NakadaKeith R Walley
Aug 13, 2011·The Journal of Infection·George LiamisMoses Elisaf
Feb 15, 2008·Critical Care Medicine·Kelly V LiangMargaret M Redfield
Dec 3, 2015·Pediatric Emergency Care·Filipa CorreiaAugusto Ribeiro
Jul 31, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Rehan ShafiqueC Robert Cooke
Jul 25, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Volker BährWolfgang Oelkers
Feb 13, 2007·Current Opinion in Pharmacology·Yukinori AraiMasao Sasamata
Jan 9, 2018·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Prakash BabalicheSajal Kamat
Jul 4, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Elizabeth B McNeelyJ Herbert Patterson
Sep 29, 2011·Clinical and Experimental Nephrology·Ramin SamTodd S Ing
Oct 23, 2010·Annals of Medicine·George LiamisMoses Elisaf
Sep 25, 2014·International Urology and Nephrology·Helbert Rondon-BerriosAntonios H Tzamaloukas
Jun 5, 2012·Critical Care Nurse·Lyne Chamberlain
Jun 10, 2010·Australian Veterinary Journal·P K HolyoakeA Collins
May 18, 2010·Hospital Practice·Robert D ZenenbergMark A Merlin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Polskie Archiwum Medycyny Wewnętrznej
Waldemar Olszewski, Jerzy Głuszek
International Journal of Cardiology
Thierry H LeJemtel, Claudia Serrano
American Journal of Nephrology
Karen E Yeates, A Ross Morton
© 2022 Meta ULC. All rights reserved